Pharmaceuticals Novartis plans to acquire Mariana Oncology to strengthen radioligand therapy pipeline Last updated: May 10, 2024 9:06 am By bexib 0 Min Read Share SHARE The agreement includes a number of radioligand therapies targeting solid tumors such as breast, prostate and lung cancer. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Comparison of ChatGPT and Gemini for SEO tasks Next Article Do you want to buy a new home? Discover interior elements that prioritize the health of your family Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Innovation and Inclusion: 3D Printed Prosthetic Limbs for Mountain Bikes — Together We Ride APS Manufacturing What does “recyclable” actually mean? Economy Google Wallet announces plans to digitize US passports and develop a new digital ID system Economy Allstate, AFCA Announce 2024 Good Works Team and Allstate Wuerfel Trophy Semifinalists Insurance